ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Roche’s Phase III Trial of Actemra in COVID-19 Misses Primary Endpoint
July 31, 2020COVACTA trial did not meet primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia, or the key secondary endpoints. -
FDA approves COVACTA trial for RA drug Actemra in COVID-19 patients
March 25, 2020Genentech has secured approval in the US to go ahead with the COVACTA trial to assess the use of its rheumatoid arthritis drug (RA drug) Actemra (tocilizumab) in COVID-19 patients.
Pharma Sources Insight January 2025
